About
Gareth is a Life Science Partner with Catapult’s GM&C Life Sciences Fund, where he has been leading and managing investments since the Fund launched in late 2015. Gareth was most recently CEO of Critical Pharmaceuticals, a clinical stage biotechnology company utilising a proprietary drug delivery technology to develop a pipeline of unique biological drug products, which raised >£4m from investors including Catapult Ventures and the Welcome Trust. Gareth was previously VP Business Development at Pharmaceutical Profiles, which he joined from Manchester-based start-up Cyprotex, where he was Commercial Director. Gareth began his career in Boston, USA as a Research Fellow at Harvard Medical School. He moved back to the UK and was based at Alderley Park for over 3 years as Bioinformatics Project Manager with AstraZeneca, before joining California-based genomics company Incyte. Gareth holds an BSc in Microbiology from Sheffield University and a PhD in Molecular Genetics from Edinburgh Univ
Position in the VCSift Database
- • 2 investors at GM&C Life Sciences Fund are tracked.
- • 1 investors hold the Life Science Partner role in VCSift. Gareth King is one of them.
- • 194 investors are based in Manchester, Manchester, United Kingdom.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Manchester, UK
Contact Information
Find more investors like Gareth
Search Investors